Global iPSC Derived Cell Drugs Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global iPSC Derived Cell Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
  • 1.2.2 Autologous iPSC Derived Cell Drugs
  • 1.2.3 Universal iPSC Derived Cell Drugs
• 1.3 Market by Application
  • 1.3.1 Global iPSC Derived Cell Drugs Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Anti-Inflammatory Repair
  • 1.3.3 Tumor Immunity
  • 1.3.4 Regenerative Medicine
  • 1.3.5 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global iPSC Derived Cell Drugs Market Perspective (2020-2031)
• 2.2 Global iPSC Derived Cell Drugs Growth Trends by Region
  • 2.2.1 Global iPSC Derived Cell Drugs Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2.2 iPSC Derived Cell Drugs Market Size by Region (2020-2031)
• 2.3 iPSC Derived Cell Drugs Market Dynamics
  • 2.3.1 iPSC Derived Cell Drugs Industry Trends
  • 2.3.2 iPSC Derived Cell Drugs Market Drivers
  • 2.3.3 iPSC Derived Cell Drugs Market Challenges
  • 2.3.4 iPSC Derived Cell Drugs Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue iPSC Derived Cell Drugs by Players
  • 3.1.1 Global iPSC Derived Cell Drugs Revenue by Players (2020-2025)
  • 3.1.2 Global iPSC Derived Cell Drugs Revenue Market Share by Players (2020-2025)
• 3.2 Global iPSC Derived Cell Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of iPSC Derived Cell Drugs, Ranking by Revenue, 2023 VS 2024 VS 2025
• 3.4 Global Market Concentration Ratio
  • 3.4.1 Global iPSC Derived Cell Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by iPSC Derived Cell Drugs Revenue in 2024
• 3.5 Global Key Players of iPSC Derived Cell Drugs Head office and Area Served
• 3.6 Global Key Players of iPSC Derived Cell Drugs, Product and Application
• 3.7 Global Key Players of iPSC Derived Cell Drugs, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

• 4.1 Global iPSC Derived Cell Drugs Historic Market Size by Type (2020-2025)
• 4.2 Global iPSC Derived Cell Drugs Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

• 5.1 Global iPSC Derived Cell Drugs Historic Market Size by Application (2020-2025)
• 5.2 Global iPSC Derived Cell Drugs Forecasted Market Size by Application (2026-2031)

6 North America

• 6.1 North America iPSC Derived Cell Drugs Market Size (2020-2031)
• 6.2 North America Market Size by Type
  • 6.2.1 North America iPSC Derived Cell Drugs Market Size by Type (2020-2031)
  • 6.2.2 North America iPSC Derived Cell Drugs Market Share by Type (2020-2031)
• 6.3 North America Market Size by Application
  • 6.3.1 North America iPSC Derived Cell Drugs Market Size by Application (2020-2031)
  • 6.3.2 North America iPSC Derived Cell Drugs Market Share by Application (2020-2031)
• 6.4 North America Market Size by Country
  • 6.4.1 North America iPSC Derived Cell Drugs Market Size by Country: 2020 VS 2024 VS 2031
  • 6.4.2 North America iPSC Derived Cell Drugs Market Size by Country (2020-2031)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe iPSC Derived Cell Drugs Market Size (2020-2031)
• 7.2 Europe Market Size by Type
  • 7.2.1 Europe iPSC Derived Cell Drugs Market Size by Type (2020-2031)
  • 7.2.2 Europe iPSC Derived Cell Drugs Market Share by Type (2020-2031)
• 7.3 Europe Market Size by Application
  • 7.3.1 Europe iPSC Derived Cell Drugs Market Size by Application (2020-2031)
  • 7.3.2 Europe iPSC Derived Cell Drugs Market Share by Application (2020-2031)
• 7.4 Europe Market Size by Country
  • 7.4.1 Europe iPSC Derived Cell Drugs Market Size by Country: 2020 VS 2024 VS 2031
  • 7.4.2 Europe iPSC Derived Cell Drugs Market Size by Country (2020-2025)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 China

• 8.1 China iPSC Derived Cell Drugs Market Size (2020-2031)
• 8.2 China Market Size by Type
  • 8.2.1 China iPSC Derived Cell Drugs Market Size by Type (2020-2031)
  • 8.2.2 China iPSC Derived Cell Drugs Market Share by Type (2020-2031)
• 8.3 China Market Size by Application
  • 8.3.1 China iPSC Derived Cell Drugs Market Size by Application (2020-2031)
  • 8.3.2 China iPSC Derived Cell Drugs Market Share by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia iPSC Derived Cell Drugs Market Size (2020-2031)
• 9.2 Asia Market Size by Type
  • 9.2.1 Asia iPSC Derived Cell Drugs Market Size by Type (2020-2031)
  • 9.2.2 Asia iPSC Derived Cell Drugs Market Share by Type (2020-2031)
• 9.3 Asia Market Size by Application
  • 9.3.1 Asia iPSC Derived Cell Drugs Market Size by Application (2020-2031)
  • 9.3.2 Asia iPSC Derived Cell Drugs Market Share by Application (2020-2031)
• 9.4 Asia Market Size by Region
  • 9.4.1 Asia iPSC Derived Cell Drugs Market Size by Region: 2020 VS 2024 VS 2031
  • 9.4.2 Asia iPSC Derived Cell Drugs Market Size by Region (2020-2031)
  • 9.4.3 Japan
  • 9.4.4 South Korea
  • 9.4.5 China Taiwan
  • 9.4.6 Southeast Asia
  • 9.4.7 India
  • 9.4.8 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America iPSC Derived Cell Drugs Market Size (2020-2031)
• 10.2 Middle East, Africa, and Latin America Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America iPSC Derived Cell Drugs Market Size by Type (2020-2031)
  • 10.2.2 Middle East, Africa, and Latin America iPSC Derived Cell Drugs Market Share by Type (2020-2031)
• 10.3 Middle East, Africa, and Latin America Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America iPSC Derived Cell Drugs Market Size by Application (2020-2031)
  • 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
• 10.4 Middle East, Africa, and Latin America Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America iPSC Derived Cell Drugs Market Size by Country: 2020 VS 2024 VS 2031
  • 10.4.2 Middle East, Africa, and Latin America iPSC Derived Cell Drugs Market Size by Country (2020-2031)
  • 10.4.3 Brazil
  • 10.4.4 Mexico
  • 10.4.5 Turkey
  • 10.4.6 Saudi Arabia
  • 10.4.7 Israel
  • 10.4.8 GCC Countries

11 Key Players Profiles

• 11.1 Shanghai UniXell Biotechnology
  • 11.1.1 Shanghai UniXell Biotechnology Company Details
  • 11.1.2 Shanghai UniXell Biotechnology Business Overview
  • 11.1.3 Shanghai UniXell Biotechnology iPSC Derived Cell Drugs Introduction
  • 11.1.4 Shanghai UniXell Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025)
  • 11.1.5 Shanghai UniXell Biotechnology Recent Development
• 11.2 HELP Therapeutics
  • 11.2.1 HELP Therapeutics Company Details
  • 11.2.2 HELP Therapeutics Business Overview
  • 11.2.3 HELP Therapeutics iPSC Derived Cell Drugs Introduction
  • 11.2.4 HELP Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
  • 11.2.5 HELP Therapeutics Recent Development
• 11.3 Hopstem Biotechnology
  • 11.3.1 Hopstem Biotechnology Company Details
  • 11.3.2 Hopstem Biotechnology Business Overview
  • 11.3.3 Hopstem Biotechnology iPSC Derived Cell Drugs Introduction
  • 11.3.4 Hopstem Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025)
  • 11.3.5 Hopstem Biotechnology Recent Development
• 11.4 Nuwacell
  • 11.4.1 Nuwacell Company Details
  • 11.4.2 Nuwacell Business Overview
  • 11.4.3 Nuwacell iPSC Derived Cell Drugs Introduction
  • 11.4.4 Nuwacell Revenue in iPSC Derived Cell Drugs Business (2020-2025)
  • 11.4.5 Nuwacell Recent Development
• 11.5 Allele Biotech
  • 11.5.1 Allele Biotech Company Details
  • 11.5.2 Allele Biotech Business Overview
  • 11.5.3 Allele Biotech iPSC Derived Cell Drugs Introduction
  • 11.5.4 Allele Biotech Revenue in iPSC Derived Cell Drugs Business (2020-2025)
  • 11.5.5 Allele Biotech Recent Development
• 11.6 BlueRock Therapeutics
  • 11.6.1 BlueRock Therapeutics Company Details
  • 11.6.2 BlueRock Therapeutics Business Overview
  • 11.6.3 BlueRock Therapeutics iPSC Derived Cell Drugs Introduction
  • 11.6.4 BlueRock Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
  • 11.6.5 BlueRock Therapeutics Recent Development
• 11.7 Century Therapeutics
  • 11.7.1 Century Therapeutics Company Details
  • 11.7.2 Century Therapeutics Business Overview
  • 11.7.3 Century Therapeutics iPSC Derived Cell Drugs Introduction
  • 11.7.4 Century Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
  • 11.7.5 Century Therapeutics Recent Development
• 11.8 Fate Therapeutics
  • 11.8.1 Fate Therapeutics Company Details
  • 11.8.2 Fate Therapeutics Business Overview
  • 11.8.3 Fate Therapeutics iPSC Derived Cell Drugs Introduction
  • 11.8.4 Fate Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
  • 11.8.5 Fate Therapeutics Recent Development
• 11.9 Cellino
  • 11.9.1 Cellino Company Details
  • 11.9.2 Cellino Business Overview
  • 11.9.3 Cellino iPSC Derived Cell Drugs Introduction
  • 11.9.4 Cellino Revenue in iPSC Derived Cell Drugs Business (2020-2025)
  • 11.9.5 Cellino Recent Development
• 11.10 Xellsmart
  • 11.10.1 Xellsmart Company Details
  • 11.10.2 Xellsmart Business Overview
  • 11.10.3 Xellsmart iPSC Derived Cell Drugs Introduction
  • 11.10.4 Xellsmart Revenue in iPSC Derived Cell Drugs Business (2020-2025)
  • 11.10.5 Xellsmart Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global iPSC Derived Cell Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Autologous iPSC Derived Cell Drugs

Table 3. Key Players of Universal iPSC Derived Cell Drugs

Table 4. Global iPSC Derived Cell Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global iPSC Derived Cell Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Market Size by Region (2020-2031) & (US$ Million)

Table 7. Global iPSC Derived Cell Drugs Market Share by Region (2020-2031)

Table 8. Market Trends

Table 9. Market Drivers

Table 10. Market Challenges

Table 11. Market Restraints

Table 12. Global iPSC Derived Cell Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 13. Global iPSC Derived Cell Drugs Market Share by Players (2020-2025)

Table 14. Global Top iPSC Derived Cell Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in iPSC Derived Cell Drugs as of 2024)

Table 15. Global iPSC Derived Cell Drugs Industry Ranking 2023 VS 2024

Table 16. Global 5 Largest Players Market Share by iPSC Derived Cell Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 17. Global Key Players of iPSC Derived Cell Drugs, Headquarters and Area Served

Table 18. Global Key Players of iPSC Derived Cell Drugs, Product and Application

Table 19. Global Key Players of iPSC Derived Cell Drugs, Date of Enter into This Industry

Table 20. Mergers & Acquisitions, Expansion Plans

Table 21. Global Market Size by Type (2020-2025) & (US$ Million)

Table 22. Global iPSC Derived Cell Drugs Revenue Market Share by Type (2020-2025)

Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 24. Global iPSC Derived Cell Drugs Revenue Market Share by Type (2026-2031)

Table 25. Global Market Size by Application (2020-2025) & (US$ Million)

Table 26. Global iPSC Derived Cell Drugs Revenue Market Share by Application (2020-2025)

Table 27. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 28. Global iPSC Derived Cell Drugs Revenue Market Share by Application (2026-2031)

Table 29. North America Market Size by Type (2020-2031) & (US$ Million)

Table 30. North America Market Size by Application (2020-2031) & (US$ Million)

Table 31. North America iPSC Derived Cell Drugs Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Market Size by Country (2020-2031) & (US$ Million)

Table 33. Europe Market Size by Type (2020-2031) & (US$ Million)

Table 34. Europe Market Size by Application (2020-2031) & (US$ Million)

Table 35. Europe iPSC Derived Cell Drugs Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Market Size by Country (2020-2025) & (US$ Million)

Table 37. China Market Size by Type (2020-2031) & (US$ Million)

Table 38. China Market Size by Application (2020-2031) & (US$ Million)

Table 39. Asia Market Size by Type (2020-2031) & (US$ Million)

Table 40. Asia Market Size by Application (2020-2025) & (US$ Million)

Table 41. Asia iPSC Derived Cell Drugs Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia Market Size by Region (2020-2031) & (US$ Million)

Table 43. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)

Table 44. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)

Table 45. Middle East, Africa, and Latin America iPSC Derived Cell Drugs Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)

Table 47. Shanghai UniXell Biotechnology Company Details

Table 48. Shanghai UniXell Biotechnology Business Overview

Table 49. Shanghai UniXell Biotechnology iPSC Derived Cell Drugs Product

Table 50. Shanghai UniXell Biotechnology Revenue (2020-2025) & (US$ Million)

Table 51. Shanghai UniXell Biotechnology Recent Development

Table 52. HELP Therapeutics Company Details

Table 53. HELP Therapeutics Business Overview

Table 54. HELP Therapeutics iPSC Derived Cell Drugs Product

Table 55. HELP Therapeutics Revenue (2020-2025) & (US$ Million)

Table 56. HELP Therapeutics Recent Development

Table 57. Hopstem Biotechnology Company Details

Table 58. Hopstem Biotechnology Business Overview

Table 59. Hopstem Biotechnology iPSC Derived Cell Drugs Product

Table 60. Hopstem Biotechnology Revenue (2020-2025) & (US$ Million)

Table 61. Hopstem Biotechnology Recent Development

Table 62. Nuwacell Company Details

Table 63. Nuwacell Business Overview

Table 64. Nuwacell iPSC Derived Cell Drugs Product

Table 65. Nuwacell Revenue (2020-2025) & (US$ Million)

Table 66. Nuwacell Recent Development

Table 67. Allele Biotech Company Details

Table 68. Allele Biotech Business Overview

Table 69. Allele Biotech iPSC Derived Cell Drugs Product

Table 70. Allele Biotech Revenue (2020-2025) & (US$ Million)

Table 71. Allele Biotech Recent Development

Table 72. BlueRock Therapeutics Company Details

Table 73. BlueRock Therapeutics Business Overview

Table 74. BlueRock Therapeutics iPSC Derived Cell Drugs Product

Table 75. BlueRock Therapeutics Revenue (2020-2025) & (US$ Million)

Table 76. BlueRock Therapeutics Recent Development

Table 77. Century Therapeutics Company Details

Table 78. Century Therapeutics Business Overview

Table 79. Century Therapeutics iPSC Derived Cell Drugs Product

Table 80. Century Therapeutics Revenue (2020-2025) & (US$ Million)

Table 81. Century Therapeutics Recent Development

Table 82. Fate Therapeutics Company Details

Table 83. Fate Therapeutics Business Overview

Table 84. Fate Therapeutics iPSC Derived Cell Drugs Product

Table 85. Fate Therapeutics Revenue (2020-2025) & (US$ Million)

Table 86. Fate Therapeutics Recent Development

Table 87. Cellino Company Details

Table 88. Cellino Business Overview

Table 89. Cellino iPSC Derived Cell Drugs Product

Table 90. Cellino Revenue (2020-2025) & (US$ Million)

Table 91. Cellino Recent Development

Table 92. Xellsmart Company Details

Table 93. Xellsmart Business Overview

Table 94. Xellsmart iPSC Derived Cell Drugs Product

Table 95. Xellsmart Revenue (2020-2025) & (US$ Million)

Table 96. Xellsmart Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Global iPSC Derived Cell Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 2. Global iPSC Derived Cell Drugs Market Share by Type: 2024 VS 2031

Figure 3. Autologous iPSC Derived Cell Drugs Features

Figure 4. Universal iPSC Derived Cell Drugs Features

Figure 5. Global iPSC Derived Cell Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Global iPSC Derived Cell Drugs Market Share by Application: 2024 VS 2031

Figure 7. Anti-Inflammatory Repair Case Studies

Figure 8. Tumor Immunity Case Studies

Figure 9. Regenerative Medicine Case Studies

Figure 10. Others Case Studies

Figure 11. iPSC Derived Cell Drugs Report Years Considered

Figure 12. Global iPSC Derived Cell Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global iPSC Derived Cell Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global iPSC Derived Cell Drugs Market Share by Region: 2024 VS 2031

Figure 15. Global iPSC Derived Cell Drugs Market Share by Players in 2024

Figure 16. Global Top iPSC Derived Cell Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in iPSC Derived Cell Drugs as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by iPSC Derived Cell Drugs Revenue in 2024

Figure 18. North America iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America iPSC Derived Cell Drugs Market Share by Type (2020-2031)

Figure 20. North America iPSC Derived Cell Drugs Market Share by Application (2020-2031)

Figure 21. North America iPSC Derived Cell Drugs Market Share by Country (2020-2031)

Figure 22. United States iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe iPSC Derived Cell Drugs Market Share by Type (2020-2031)

Figure 26. Europe iPSC Derived Cell Drugs Market Share by Application (2020-2031)

Figure 27. Europe iPSC Derived Cell Drugs Market Share by Country (2020-2031)

Figure 28. Germany iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. China iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. China iPSC Derived Cell Drugs Market Share by Type (2020-2031)

Figure 36. China iPSC Derived Cell Drugs Market Share by Application (2020-2031)

Figure 37. Asia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia iPSC Derived Cell Drugs Market Share by Type (2020-2031)

Figure 39. Asia iPSC Derived Cell Drugs Market Share by Application (2020-2031)

Figure 40. Asia iPSC Derived Cell Drugs Market Share by Region (2020-2031)

Figure 41. Japan iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. China Taiwan iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Southeast Asia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. India iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Australia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America iPSC Derived Cell Drugs Market Share by Type (2020-2031)

Figure 49. Middle East, Africa, and Latin America iPSC Derived Cell Drugs Market Share by Application (2020-2031)

Figure 50. Middle East, Africa, and Latin America iPSC Derived Cell Drugs Market Share by Country (2020-2031)

Figure 51. Brazil iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Mexico iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Turkey iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Israel iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. GCC Countries iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Shanghai UniXell Biotechnology Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 58. HELP Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 59. Hopstem Biotechnology Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 60. Nuwacell Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 61. Allele Biotech Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 62. BlueRock Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 63. Century Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 64. Fate Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 65. Cellino Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 66. Xellsmart Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed